Age-Period-Cohort Analysis of Liver Cancer Mortality in Korea

  • Park, Jihwan (Department of Applied Statistics, Graduate School, Yonsei University) ;
  • Jee, Yon Ho (Department of Statistics, Sookmyung Women's University)
  • Published : 2016.01.11


Background: Liver cancer is one of the most common causes of death in the world. In Korea, hepatitis B virus (HBV) is a major risk factor for liver cancer but infection rates have been declining since the implementation of the national vaccination program. In this study, we examined the secular trends in liver cancer mortality to distinguish the effects of age, time period, and birth cohort. Materials and Methods: Data for the annual number of liver cancer deaths in Korean adults (30 years and older) were obtained from the Korean Statistical Information Service for the period from 1984-2013. Joinpoint regression analysis was used to study the shapes of and to detect the changes in mortality trends. Also, an age-period-cohort model was designed to study the effect of each age, period, and birth cohort on liver cancer mortality. Results: For both men and women, the age-standardized mortality rate for liver cancer increased from 1984 to 1993 and decreased thereafter. The highest liver cancer mortality rate has shifted to an older age group in recent years. Within the same birth cohort group, the mortality rate of older age groups has been higher than in the younger age groups. Age-period-cohort analysis showed an association with a high mortality rate in the older age group and in recent years, whereas a decreasing mortality rate were observed in the younger birth cohort. Conclusions: This study confirmed a decreasing trend in liver cancer mortality among Korean men and women after 1993. The trends in mortality rate may be mainly attributed to cohort effects.


  1. Ahmad OB, Boschi-Pinto C, Lopez AD, et al (2001). Age standardization of rates: a new WHO standard. World Health Organization Geneva.
  2. Benhamiche A-M, Faivre C, Minello A, et al (1998). Time trends and age-period-cohort effects on the incidence of primary liver cancer in a well-defined French population: 1976-1995. J Hepatol, 29, 802-6.
  3. Chae HB, Kim J-H, Kim JK, et al (2009). Current status of liver diseases in Korea: hepatitis B. Korean J Hepatol, 15, S13-S24.
  4. Dal Maso L, Lise M, Zambon P, et al (2008). Incidence of primary liver cancer in Italy between 1988 and 2002: An age-period-cohort analysis. Eur J Cancer, 44, 285-92.
  5. Fang JW, Lai C, Chung H, et al (1994). Female children respond to recombinant hepatitis B vaccine with a higher titre than male. J Trop Pediatr, 40, 104-7.
  6. Ferlay J, Soerjomataram I, Ervik M, et al GLOBOCAN 2012 v1. 0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer; 2013. [cited 2015 Sep 13].
  7. Fritz A, Percy C, Jack A, et al (2000). International classification of diseases for oncology. World Health Organization.
  8. Gwack J, Park SK, Lee EH, et al (2011). Hepatitis B vaccination and liver cancer mortality reduction in Korean children and adolescents. Asian Pac J Cancer Prev, 12, 2205-8.
  9. Jiang X, Pan SY, de Groh M, et al (2011). Increasing incidence in liver cancer in Canada, 1972-2006: Age-period-cohort analysis. J Gastrointest Oncol, 2, 223.
  10. Jo MW, Khang YH, Yun S, et al (2004). Proportion of death certificates issued by physicians and associated factors in Korea, 1990-2002. J Prev Med Public Health, 37, 345-52.
  11. Jung K-W, Park S, Kong H-J, et al (2012). Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2009. Cancer Res Treat, 44, 11-24.
  12. Jung KW, Won YJ, Kong HJ, et al (2015). Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2012. Cancer Res Treat, 47, 127.
  13. Kim H, Shin AR, Chung HH, et al (2013). Recent trends in hepatitis B virus infection in the general Korean population. Korean J Intern Med, 28, 413-9.
  14. Kim HJ, Fay MP, Feuer EJ, et al (2000). Permutation tests for joinpoint regression with applications to cancer rates. Stat Med, 19, 335-51.<335::AID-SIM336>3.0.CO;2-Z
  15. Kim SB, Lee WK, Choi H, et al (2009). A study on viral hepatitis markers and abnormal liver function test in adults living in northwest area of Chungnam. Korean J Gastroenterol, 53, 355-60.
  16. Lee BS, Cho YK, Jeong SH, et al (2013). Nationwide seroepidemiology of hepatitis B virus infection in South Korea in 2009 emphasizes the coexistence of HBsAg and anti-HBs. J Med Virol, 85, 1327-33.
  17. Lee KI, Park KS, Seo HJ, et al (2011). Shifting in seroprevalence of HBsAg and anti-HCV during recent 10 years in adults resident in Daegu and Gyeongbuk Province. Korean J Gastroenterol, 58, 82-7.
  18. Lin HH, Wang LY, Hu CT, et al (2003). Decline of hepatitis B carrier rate in vaccinated and unvaccinated subjects: sixteen years after newborn vaccination program in Taiwan. J Med Virol, 69, 471-4.
  19. Matsuda T, Saika K (2012). Trends in liver cancer mortality rates in Japan, USA, UK, France and Korea based on the WHO mortality database. Jpn J Clin Oncol, 42, 360-1.
  20. Morales S-VM, LlopisGonzalez L, Tejerizo PM (1993). Mortality rates of liver cancer in Spain: effect of age, birth cohort, and period of death. J Environ Pathol Toxicol Oncol, 13, 43-7.
  21. Park KS, Lee YS, Lee SG, et al (2003). A study on markers of viral hepatitis in adults living in Daegu and Gyungbuk area. Korean J Gastroenterol, 41, 473-9.
  22. Reither EN, Hauser RM, Yang Y (2009). Do birth cohorts matter? Age-period-cohort analyses of the obesity epidemic in the United States. Soc Sci Med, 69, 1439-48.
  23. Statistics Korea [Internet]. Daejeon: Statistics Korea; 2013. [cited 2015 Oct 1].
  24. Tzeng IS, Lee WC (2015). Forecasting hepatocellular carcinoma mortality in Taiwan using an age-period-cohort model. Asia Pac J Public Health, 27, 65-73.
  25. Wang P, Xu C, Yu C (2014). Age-period-cohort analysis on the cancer mortality in rural China: 1990-2010. Int J Equity Health, 13, 1-12.
  26. WHO (2009). Hepatitis B vaccines. Wkly Epidemiol Rec, 84, 405-19.
  27. Yang Y (2008). Trends in US adult chronic disease mortality, 1960-1999: age, period, and cohort variations. Demography, 45, 387-416.
  28. Yang Y, Fu WJ, Land KC (2004). A Methodological Comparison of Age-Period-Cohort Models: The Intrinsic Estimator and Conventional Generalized Linear Models. Sociol Methodol, 34, 75-110.
  29. Yeo Y, Gwack J, Kang S, et al (2013). Viral hepatitis and liver cancer in Korea: an epidemiological perspective. Asian Pac J Cancer Prev, 14, 6227-31.
  30. Zeeshan M, Jabeen K, Ali AN, et al (2007). Evaluation of immune response to Hepatitis B vaccine in health care workers at a tertiary care hospital in Pakistan: an observational prospective study. BMC Infect Dis, 7, 120.

Cited by

  1. Comparison of Secular Trends in Cervical Cancer Mortality in China and the United States: An Age-Period-Cohort Analysis vol.13, pp.11, 2016,
  2. Trends in the Mortality of Hepatocellular Carcinoma in the United States vol.21, pp.12, 2017,
  3. Liver Cancer Mortality at National and Provincial Levels in Iran Between 1990 and 2015: A Meta Regression Analysis vol.18, pp.1, 2018,